Similar articles

• Mechanisms of action of intravenous immunoglobulins.

  Baerenwaldt A, Biburger M, Nimmerjahn F. Baerenwaldt A, et al. Expert Rev Clin Immunol. 2010 May;6(3):425-34. doi: 10.1586/eci.10.9. Expert Rev Clin Immunol. 2010. PMID: 20441428 Review.
• Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

  Kazatchkine MD, Kaveri SV. Kazatchkine MD, et al. N Engl J Med. 2001 Sep 6;345(10):747-55. doi: 10.1056/NEJMra993360. N Engl J Med. 2001. PMID: 11547745 Review. No abstract available.
• Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.

  Sibéril S, Elluru S, Graff-Dubois S, Negi VS, Delignat S, Mouthon L, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, Kaveri SV. Sibéril S, et al. Ann N Y Acad Sci. 2007 Sep;1110:497-506. doi: 10.1196/annals.1423.052. Ann N Y Acad Sci. 2007. PMID: 17911465
• Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.

  Ruiz de Souza V, Kaveri SV, Kazatchkine MD. Ruiz de Souza V, et al. Clin Exp Rheumatol. 1993 May-Jun;11 Suppl 9:S33-6. Clin Exp Rheumatol. 1993. PMID: 8354005 Review.
• Intravenous immunoglobulin and immune response.

  Kaveri SV, Lecerf M, Saha C, Kazatchkine MD, Lacroix-Desmazes S, Bayry J. Kaveri SV, et al. Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):94-6. doi: 10.1111/cei.12526. Clin Exp Immunol. 2014. PMID: 25546777 Free PMC article. No abstract available.